As of November 2024 Arrowhead Pharmaceuticals has 106.75M shares outstanding, a increase of 1.26% from 2023. It represents the total number of shares of a company that are owned by all its shareholders, including both public investors and company insiders.
Year | Shares outstanding | Change |
---|---|---|
2023 | 106.75M | 1.26% |
2022 | 105.43M | 1.62% |
2021 | 103.75M | 3.00% |
2020 | 100.72M | - |